Position in TLRY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$154,298
-$120,670 QoQ
Shares Held
34,365
-19.1% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 235 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $1,945,758,306 across 45 Drug Manufacturers - Specialty & Generic names. TLRY ranks #41 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,523,018 | $396,884,069 | |
| 2 | VTRS |
Viatris Inc
|
20,771,275 | $329,847,840 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
473,109 | $256,344,645 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,077,317 | $181,571,000 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
5,306,326 | $130,588,679 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,430,011 | $116,208,767 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,842,983 | $75,617,590 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
1,882,499 | $68,146,461 |
All Filings in TLRY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $154,298 | 34,365 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $274,968 | 42,499 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $373,110 | 41,319 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,458,178 | 842,878 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $513,141 | 1,251,567 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,104,402 | 1,673,338 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,712,591 | 2,039,543 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,602,584 | 2,046,923 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,383,083 | 2,038,003 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,840,233 | 1,959,609 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $673,057 | 292,634 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $700,436 | 293,070 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $461,926 | 296,107 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $804,983 | 318,176 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $334,711 | 124,428 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $330,530 | 120,193 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $381,559 | 122,295 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $780,534 | 100,455 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $375,535 | 53,419 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $555,953 | 49,243 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $886,462 | 49,030 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $255,462 | 11,239 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||